46 results
Page 2 of 3
424B5
dp36hc
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
EX-99.2
3fl5y
14 Sep 22
Other Events
7:05am
8-K
EX-99.2
zkcunnn
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.2
1h7 2ehp8iz9nvuh7j
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
2hg6laxdj0ejyq3noq5d
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
hcdh3qd67pmo ygzgd
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
EX-99.2
hgfrms3 614sp
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.1
nypm5ggbh 39t
1 Jul 21
Other Events
6:11am
8-K
EX-99.1
pvkp6mvr
14 Jun 21
Other Events
5:21pm
8-K
EX-99.1
kvpz vlo61zmzwjd
18 May 21
Other Events
3:09pm
8-K
EX-99.1
eth5deb7kuiz2gr1x59
8 Dec 20
Regulation FD Disclosure
7:40am
8-K
EX-99.2
i6ih9fk11oanueq9y28
10 Nov 20
Larimar Therapeutics Reports Third Quarter 2020 Operating and Financial Results
4:23pm
8-K
EX-99.2
j36 eflajl9yn
11 Aug 20
Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
7:38am
8-K
EX-99.1
m3gb0gn
6 Aug 20
Departure of Directors or Certain Officers
9:00am
8-K
EX-99.1
j4bta4kls mg
3 Jun 20
Regulation FD Disclosure
12:00am